Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002340938 | SCV002642502 | uncertain significance | Inborn genetic diseases | 2019-01-08 | criteria provided, single submitter | clinical testing | The p.P175L variant (also known as c.524C>T), located in coding exon 5 of the NIPBL gene, results from a C to T substitution at nucleotide position 524. The proline at codon 175 is replaced by leucine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Center For Human Genetics And Laboratory Diagnostics, |
RCV003096668 | SCV003035359 | uncertain significance | Cornelia de Lange syndrome 1 | 2022-09-16 | criteria provided, single submitter | clinical testing |